FMC vs ZYME · rev $1.22B vs rev $76.3M
FMC Corporation (FMC) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
FMC Corporation (FMC) is a agricultural inputs company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported FMC revenue for 2024-12-31 was $1.22B. Net income was -$16.1M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. FMC currently screens at market cap $1.50B.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
FMC currently screens at market cap $1.50B. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the FMC and ZYME stock pages for the full models.
Not investment advice.